Document is current
Any future updates will be listed below
-
Authors
Gallwitz, Maike https://orcid.org/0000-0001-9030-5470
Lindqvist, Isa https://orcid.org/0000-0002-5384-2805
Mulder, Jan https://orcid.org/0000-0003-3717-5018
Rasmusson, Annica J. https://orcid.org/0000-0002-7228-7755
Larsson, Anders
Husén, Evelina
Borin, Jesper
van der Spek, Peter J. https://orcid.org/0000-0002-2203-0652
Sabbagh, Nour
Widgren, Anna
Bergquist, Jonas https://orcid.org/0000-0002-4597-041X
Cervenka, Simon
Burman, Joachim
Cunningham, Janet L. https://orcid.org/0000-0001-7876-7779
- License Information
-
More Information
Article History
Received: 29 September 2023
Revised: 2 September 2024
Accepted: 5 September 2024
First Online: 21 September 2024
Competing interests
: JLC has received lecturing fees from Otsuka Pharma Scandinavia, Janssen-Cilag AB and H. Lundbeck AB.
